NCT07393971

Brief Summary

This study is developing and testing a new controller for a robotic ankle exoskeleton (Biomotum) that can adjust itself in real time to better support people while they walk. The system learns how each person moves and automatically changes the amount and timing of assistance to make walking feel easier and more efficient. By using information from the person wearing the device, the exoskeleton can quickly find the level of support that works best for them. The long-term goal is to create personalized walking assistance that can help people with mobility limitations move more comfortably and with less effort.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Feb 2026Dec 2026

First Submitted

Initial submission to the registry

December 5, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 6, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 6, 2026

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

December 5, 2025

Last Update Submit

January 30, 2026

Conditions

Keywords

robotic ankle exoskeletonhuman-in-the-loop optimizationwearable roboticsmusculoskeletal modelingmuscle activation analysis

Outcome Measures

Primary Outcomes (1)

  • Successful Real-Time Operation of the Robotic Ankle Exoskeleton Controller

    Device feasibility will be evaluated by the successful real-time operation of the robotic ankle exoskeleton and adaptive controller during treadmill walking. Feasibility is defined as the controller's ability to continuously generate, update, and apply assistive torque in real time based on incoming biomechanical and physiological data without system failure, interruption, or safety-related termination. Successful operation will be confirmed by continuous controller function and synchronized data acquisition across walking trials.

    through study completion, an average of 1 year

Secondary Outcomes (5)

  • Net Metabolic Rate During Exoskeleton-Assisted Walking Measured by Indirect Calorimetry

    through study completion, an average of 1 year

  • Estimated Metabolic Rate Derived From Joint-Space Musculoskeletal Modeling

    through study completion, an average of 1 year

  • Estimated Lower-Limb Muscle Activation Derived From Joint-Space Musculoskeletal Modeling

    through study completion, an average of 1 year

  • Lower-Limb Muscle Activation Measured by Surface Electromyography During Walking

    through study completion, an average of 1 year

  • During treadmill walking trials conducted at a single study visit

    through study completion, an average of 1 year

Study Arms (1)

Single-Arm Study of a Personalized Robotic Ankle Exoskeleton Controller

EXPERIMENTAL

This arm employs a within-subject design with two methods of estimating metabolic cost versus the gold standard measure of metabolic cost, wherein a single participant is subjected to two distinct measurements. This design allows for a direct comparison of the effects of each method (i.e., estimation versus gold standard) within the same individual, minimizing intersubject variability and enhancing the statistical power of the analysis.

Device: Adaptive Torque Control System for Ankle Exoskeleton

Interventions

This intervention uses a robotic ankle exoskeleton equipped with a real-time adaptive controller that adjusts plantarflexion torque based on each participant's walking mechanics. Unlike standard exoskeleton controllers that use fixed or pre-programmed assistance levels, this system employs human-in-the-loop optimization to continuously update torque magnitude and timing during treadmill walking. The controller integrates metabolic estimations, kinematic data, and musculoskeletal modeling to identify individualized assistance patterns that reduce walking effort and improve muscle activation efficiency. Participants complete multiple walking trials while the controller automatically modifies assistance to determine the optimal personalized settings.

Single-Arm Study of a Personalized Robotic Ankle Exoskeleton Controller

Eligibility Criteria

Age19 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • able to walk independently on a treadmill for 10 minutes,
  • free of neurological, cardiovascular, pulmonary, or musculoskeletal conditions that limit walking and exercising,
  • no current lower extremity pain or injury,
  • able to wear an exoskeleton and safety harness, can provide informed consent

You may not qualify if:

  • history of neurological disease that affected gait or balance,
  • current or recent lower extremity musculoskeletal injury or surgery,
  • chronic lower extremity pain during walking,
  • inability to participate in moderate-intensity exercise,
  • require an assistive device for walking,
  • any metabolic or systemic diseases that may be exacerbated by exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Biomechanics Research Building, University of Nebraska at Omaha

Omaha, Nebraska, 68108, United States

Location

Study Officials

  • Farah Fallahtafti, PhD

    Department of Biomechanics, University of Nebraska at Omaha

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Farah Fallahtafi, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2025

First Posted

February 6, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 6, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

IPD will not be shared because direct measurements are only taken for baseline measurements that the modeling software will be using. The scripts and code used will be shared through opensource, but that does not include subject data.

Locations